These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 26322474)

  • 1. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
    Rahme K; Guo J; Holmes JD; O'Driscoll CM
    Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
    Guo J; O'Driscoll CM; Holmes JD; Rahme K
    Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
    Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer.
    Minassian G; Ghanem E; Hage RE; Rahme K
    Nanotheranostics; 2023; 7(2):152-166. PubMed ID: 36793347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery.
    Xu CF; Zhang HB; Sun CY; Liu Y; Shen S; Yang XZ; Zhu YH; Wang J
    Biomaterials; 2016 May; 88():48-59. PubMed ID: 26945455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
    Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
    Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthogonal analysis of functional gold nanoparticles for biomedical applications.
    Tsai DH; Lu YF; DelRio FW; Cho TJ; Guha S; Zachariah MR; Zhang F; Allen A; Hackley VA
    Anal Bioanal Chem; 2015 Nov; 407(28):8411-22. PubMed ID: 26362156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles.
    Kumar K; Vulugundam G; Jaiswal PK; Shyamlal BRK; Chaudhary S
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4288-4293. PubMed ID: 28838699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
    Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S
    Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of gold nanoparticle surface co-functionalization approaches using Polyethylene Glycol (PEG) and the effect on stability, non-specific protein adsorption and internalization.
    Harrison E; Nicol JR; Macias-Montero M; Burke GA; Coulter JA; Meenan BJ; Dixon D
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():710-8. PubMed ID: 26952476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
    Rahme K; Guo J; Holmes JD
    Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced delivery of biodegradable mPEG-PLGA-PLL nanoparticles loading Cy3-labelled PDGF-BB siRNA by UTMD to rat retina.
    DU J; Sun Y; Li FH; DU LF; Duan YR
    J Biosci; 2017 Jun; 42(2):299-309. PubMed ID: 28569253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles.
    Liu X; Huang N; Wang H; Li H; Jin Q; Ji J
    Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
    Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
    Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.